Invest in SynergyMed Cancer Treatment Technology
Ground Breaking Cancer Treatment: Tumors Vanish Within Few Days
Highlights
1
Signed LOI's from Boston Scientific and Medtronic.
2
$100 million projected revenue within 5 years (not guaranteed).
3
10 minute non-invasive treatment to cure cancer in dogs and mice.
4
Building collaborations with leading U.S. institutions including Ohio State and Harvard.
Featured Investor
Invested $5,000
Invested $5,000 this round
“Cancer treatment has long been associated with daunting procedures, lengthy recovery periods, and a profound impact on quality of life. Traditional surgery, while often effective, can be invasive and painful, leaving patients and their families searching for better alternatives. In this landscape, SynergyMed stands out as a beacon of hope, offering a revolutionary approach to cancer treatment. SynergyMed” precise, noninvasive methodology marks a significant leap forward in oncology. Their cut...”
Our Team
CEO
25+ years of technical & leadership experiences,
RMD: Radiation Monitoring Devices, Intel: Biochips, Harvard Medical School: MRI
VP of Business Development
Medical Technology Entrepreneur. Co-founded NCA Monitoring Technologies & D&O LLC
ADNOC Oil Company
Corporate Planning, Finance, Performance, and Business Development
Daniel Kacher, Ph.D.Director of Clinical Studies and Product Development
Ph.D. in Biomedical Engineering
25 years at Brigham and Women’s Hospital
The Non-Surgical 10 Min Solution to Destroy Cancer Tumors
Mouse experiment showing complete disappearance of cancer tumors within 3 days using SynergyMed's noninvasive technology, with no visible damage to surrounding tissue.
